SkyePharma News
Most Popular SkyePharma Story
FDA rejects SkyePharma's NDA for Flutiform
The U.K.'s SkyePharma says the FDA has officially rebuffed its NDA for the asthma drug Flutiform, its lead drug prospect, spelling out "substantive" issues that need to be resolved ahead of an Read more...
Latest Headlines
- August 20, 2010
- June 24, 2010
- January 21, 2010
- September 1, 2009
- June 9, 2009
- March 23, 2009
- November 2, 2007
- August 6, 2007
- November 5, 2006
- May 21, 2006
- May 7, 2006
- April 20, 2006
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
